Ketorolac

2

Review clinical trials related to Ketorolac. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Atomized Intranasal Ketorolac at 30 mg Versus 20 mg for the Treatment of Acute Pain in the Emergency Department

This study aims to compare the analgesic effectiveness and side effects of intranasal ketorolac at 30 mg Versus 20 mg for the Treatment of Acute moderate and severe Pain in the Emergency Department.

Participants needed: 100
Trial details
Phase: Phase 3Age: 18-65Biological sex: AllType: InterventionalSponsor: Tehran University of Medical SciencesUpdated: Sep 16, 2026
Eligibility criteria

Age: 18-65 years [+3]

Active peptic ulcer disease (PUD) [+26]